EAM
NVO

Eagle Asset Management’s Novo Nordisk NVO Stock Holding History

Eagle Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.92M Buy
17,893
+1,680
+10% +$224K 0.01% 463
2024
Q2 		$2.36M Sell
16,213
-524
-3% -$69.4K 0.01% 460
2024
Q1 		$2.13M Sell
16,737
-517
-3% -$61.5K 0.01% 467
2023
Q4 		$1.78M Sell
17,254
-925
-5% -$91.5K 0.01% 459
2023
Q3 		$1.65M Sell
18,179
-515
-3% -$45.4K 0.01% 453
2023
Q2 		$1.51M Sell
18,694
-680
-4% -$55.5K 0.01% 456
2023
Q1 		$1.54M Sell
19,374
-382
-2% -$27.1K 0.01% 455
2022
Q4 		$1.35M Sell
19,756
-432
-2% -$25.3K 0.01% 457
2022
Q3 		$1M Buy
20,188
+2,666
+15% +$143K 0.01% 475
2022
Q2 		$976K Buy
17,522
+5,668
+48% +$315K 0.01% 492
2022
Q1 		$658K Sell
11,854
-7,884
-40% -$405K ﹤0.01% 527
2021
Q4 		$1.1M Buy
19,738
+442
+2% +$23.9K ﹤0.01% 521
2021
Q3 		$926K Buy
19,296
+5,500
+40% +$266K ﹤0.01% 521
2021
Q2 		$577K Buy
13,796
+766
+6% +$29.7K ﹤0.01% 540
2021
Q1 		$440K Buy
13,030
+5,744
+79% +$205K ﹤0.01% 549
2020
Q4 		$254K Sell
7,286
-21,504
-75% -$743K ﹤0.01% 494
2020
Q3 		$1.01M Sell
28,790
-1,280
-4% -$42.7K 0.01% 477
2020
Q2 		$985K Sell
30,070
-314
-1% -$10K 0.01% 489
2020
Q1 		$914K Sell
30,384
-1,402
-4% -$41.7K 0.01% 529
2019
Q4 		$919K Sell
31,786
-3,338
-10% -$92.4K ﹤0.01% 565
2019
Q3 		$907K Buy
+35,124
New +$888K ﹤0.01% 553
2016
Q2 		– Sell
-9,276
Closed -$251K – 648
2016
Q1 		$251K Hold
9,276
– – ﹤0.01% 607
2015
Q4 		$269K Hold
9,276
– – ﹤0.01% 616
2015
Q3 		$251K Sell
9,276
-10
-0.1% -$283 ﹤0.01% 626
2015
Q2 		$254K Buy
+9,286
New +$261K ﹤0.01% 629

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Eagle Asset Management's NVO Position: Q3 2024 in Review

Eagle Asset Management increased its Novo Nordisk (NVO) stake by 10% in Q3 2024, buying an estimated $224K and bringing the position to 17,893 shares worth $1.92M. The position accounts for 0.01% of the portfolio, ranked #463.

Eagle Asset Management first reported a position in NVO in Q2 2015 and has held it in 25 quarters since. The position peaked at $2.36M in Q2 2024. 1,786 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Eagle Asset Management held 17,893 shares of Novo Nordisk worth $1.92M as of Q3 2024.
  • Eagle Asset Management bought 1,680 Novo Nordisk shares in Q3 2024, an estimated $224K.
  • Novo Nordisk made up 0.01% of Eagle Asset Management's portfolio in Q3 2024, its #463 holding.
  • Eagle Asset Management first reported a position in Novo Nordisk in Q2 2015 and has held it in 25 quarters since.
  • Eagle Asset Management's Novo Nordisk position peaked at $2.36M in Q2 2024.
  • 1,786 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.